Compare AGNCM & YDESW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
Current Price
| Metric | AGNCM | YDESW |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | 54 | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | AGNCM | YDESW |
|---|---|---|
| Price | $24.93 | $0.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 13.2K | 7.8K |
| Earning Date | 01-26-2026 | N/A |
| Dividend Yield | ★ 8.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.57 | N/A |
| Revenue Next Year | $63.17 | N/A |
| P/E Ratio | $17.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.63 | $0.36 |
| 52 Week High | $25.34 | $2.85 |
| Indicator | AGNCM | YDESW |
|---|---|---|
| Relative Strength Index (RSI) | 52.55 | 48.19 |
| Support Level | $24.80 | $0.45 |
| Resistance Level | $25.04 | $0.58 |
| Average True Range (ATR) | 0.12 | 0.04 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 31.33 | 50.56 |
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.